Patents by Inventor Peter Stephen Fitzgerald

Peter Stephen Fitzgerald has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tilidine Immunodetection
    Publication number: 20150185241
    Abstract: An immunoassay for the detection of tilidine and nortilidine is described. The invention also describes antibodies and kits.
    Type: Application
    Filed: December 19, 2014
    Publication date: July 2, 2015
    Inventors: Elouard Benchikh, Peter Stephen Fitzgerald, Ivan McConnell, Philip Lowry
  • Sensitive and generic antibodies and multiple applications
    Patent number: 8735556
    Abstract: The invention relates to the detection and quantification of carbamazepine drugs and their metabolites. The invention is underpinned by novel polyclonal antibodies with unique binding properties which enable immunoassay methods and kits for various applications.
    Type: Grant
    Filed: June 18, 2012
    Date of Patent: May 27, 2014
    Assignee: Randox Laboratories Limited
    Inventors: Elouard Benchikh, Andrew Philip Lowry, Ivan McConnell, Peter Stephen Fitzgerald
  • Glutathione S-transferase omega 1 wild type specific antibody
    Patent number: 8617828
    Abstract: The invention relates to a novel antibody which binds to wild type (wt) Glutathione S-transferase Omega 1 (wtGSTO1) but not to mutant (mut) GSTO1 and methods and uses based on the antibody. The antibody is based on novel haptens and immunogens.
    Type: Grant
    Filed: March 15, 2012
    Date of Patent: December 31, 2013
    Assignee: Randox Laboratories Limited
    Inventors: Peter Stephen Fitzgerald, Ivan Robert McConnell, Philip Andrew Lowry, Elouard Benchikh
  • SENSITIVE AND GENERIC ANTIBODIES AND MULTIPLE APPLICATIONS
    Publication number: 20120322089
    Abstract: The invention relates to the detection and quantification of carbamazepine drugs and their metabolites. The invention is underpinned by novel polyclonal antibodies with unique binding properties which enable immunoassay methods and kits for various applications.
    Type: Application
    Filed: June 18, 2012
    Publication date: December 20, 2012
    Applicant: Randox Laboratories Limited
    Inventors: Elouard Benchikh, Andrew Philip Lowry, Ivan McConnell, Peter Stephen Fitzgerald
  • Glutathione S-Transferase Omega 1 Wild Type Specific Antibody
    Publication number: 20120237947
    Abstract: The invention relates to a novel antibody which binds to wild type (wt) Glutathione S-transferase Omega 1 (wtGSTO1) but not to mutant (mut) GSTO1 and methods and uses based on the antibody. The antibody is based on novel haptens and immunogens.
    Type: Application
    Filed: March 15, 2012
    Publication date: September 20, 2012
    Inventors: Peter Stephen Fitzgerald, Ivan Robert McConnell, Philip Andrew Lowry, Elouard Benchikh